HCA HCA Healthcare, Inc. Common Stock

NYSE · Health Care · View on SEC EDGAR ↗
$417.03
Price · Aug 19, 2026
Fundamentals as of Jul 28, 2026

About HCA Healthcare, Inc. Common Stock Company overview from Wikipedia

HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

Read more

HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

History

Early years

The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was serving as chief executive.

The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.

Growth and merger

The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.

In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.

In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,

to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.

Columbia Hospital Corporation

In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.

In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.

Recent history

On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.

In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.

In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.

In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.

In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.

In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.

In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.

In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.

Facilities

United States

As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.

Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.

In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.

In 2019 they purchased Mission Health System which operates hospitals in North Carolina.

In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.

In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.

United Kingdom

HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:

It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.

The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.

The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.

Significant areas of operation

Medical education

In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.

Controversies

Medicare billing practices lawsuit

In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.

The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.

2005 insider trading suit

In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.

COVID-19 PPE

During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.

Mission Hospital Acquisition Complaints

On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.

On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

HCA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$417.03
Market Cap
$93.67B
P/E (TTM)
14.7
EPS (TTM)
$28.33
Revenue (TTM)
$75.60B
Div Yield
0.73%
ROE
-159.1%
Debt/Equity
-6.9
52W Range
$354 – $557

HCA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $75.60B
10-point trend, +82.2%
2016-12-31 2025-12-31
EPS $28.33
10-point trend, +288.1%
2016-12-31 2025-12-31
Free Cash Flow $7.69B
10-point trend, +165.9%
2016-12-31 2025-12-31
Margins 9.0%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
HCA
Peer Median
P/E (TTM)
5-point trend, +35.7%
14.7
20.3
P/S (TTM)
5-point trend, +3.8%
1.2
1.1
P/B
5-point trend, +79.3%
-15.5
4.5
EV / EBITDA
5-point trend, +5.5%
38.1
Price / FCF
5-point trend, -6.5%
12.2

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
HCA
Peer Median
Net Profit Margin
5-point trend, -24.2%
9.0%
7.4%
ROA
5-point trend, -20.3%
11.3%
6.6%
ROE
5-point trend, +95.9%
-159.1%
23.2%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
HCA
Peer Median
Debt / Equity
5-point trend, +81.4%
-6.9
Current Ratio
5-point trend, -31.7%
1.0
1.2
Quick Ratio
5-point trend, -26.9%
0.7

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
HCA
Peer Median
Revenue YoY
5-point trend, +28.7%
7.1%
Revenue CAGR 3Y
5-point trend, +28.7%
7.9%
Revenue CAGR 5Y
5-point trend, +28.7%
8.0%
EPS YoY
5-point trend, +33.9%
28.8%
Net Income YoY
5-point trend, -2.5%
17.8%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
HCA
Peer Median
EPS (Diluted)
5-point trend, +33.9%
$28.33

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
HCA
Peer Median
Payout Ratio
5-point trend, +11.6%
10.0%

Dividends Yield, payout ratio, dividend history, 5Y CAGR

Dividend Yield
0.73%
Payout Ratio
10.0%
5Y Div CAGR
Ex-dateAmount
June 16, 2026$0.7800
March 17, 2026$0.7800
Dec. 15, 2025$0.7200
Sept. 16, 2025$0.7200
June 16, 2025$0.7200
March 17, 2025$0.7200
Dec. 13, 2024$0.6600
Sept. 16, 2024$0.6600
June 14, 2024$0.6600
March 14, 2024$0.6600
Dec. 13, 2023$0.6000
Sept. 14, 2023$0.6000
June 15, 2023$0.6000
March 16, 2023$0.6000
Dec. 13, 2022$0.5600
Sept. 15, 2022$0.5600
June 15, 2022$0.5600
March 16, 2022$0.5600
Dec. 13, 2021$0.4800
Sept. 15, 2021$0.4800

HCA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 30 analysts
  • Strong Buy 6 20.0%
  • Buy 11 36.7%
  • Hold 12 40.0%
  • Sell 1 3.3%
  • Strong Sell 0 0.0%

12-Month Price Target

21 analysts · 2026-08-17
Median target $450.00 +7.9%
Mean target $454.57 +9.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.49%
Period EPS Actual EPS Est Surprise
June 30, 2026 $7.62 $7.54 0.08%
March 31, 2026 $7.15 $7.21 -0.06%
Dec. 31, 2025 $8.14 $7.53 0.61%
Sept. 30, 2025 $6.96 $5.77 1.2%
June 30, 2025 $6.83 $6.31 0.52%
March 31, 2025 $6.45 $5.84 0.61%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
HCA $104.86B 16.5 7.1% 9.0% -159.1%
THC $17.28B 12.8 3.1% 11.1% 56.4%
EHC $10.61B 19.2 10.5% 9.5% 25.1%
ENSG $10.12B 29.8 18.7% 6.8% 16.9%
UHS 9.4 9.7% 8.6% 21.4%
PACS $6.01B 31.5 29.3% 3.6% 23.1%
CON $2.53B 15.1 13.9% 7.7% 49.8%
BKD $2.57B -9.6 2.2% -8.2% -313.2% 26.2%
ACHC $1.28B -1.2 5.0% -33.3% -43.9%
SGRY $2.00B -25.3 6.2% -2.4% -4.5%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 12
Annual Income Statement data for HCA
Metric Trend 2025202420232022202120202019201820172016
Revenue 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
SG&A Expense 10-point trend, +59.8% $548M $421M $353M $307M $337M $416M $370M $344M $340M $343M
Operating Expenses 10-point trend, +79.3% $65.77B $62.08B $57.26B $51.65B $48.92B $46.10B $46.09B $41.34B $39.23B $36.68B
Interest Expense 10-point trend, +31.7% $2.25B $2.06B $1.94B $1.74B $1.57B $1.58B $1.82B $1.75B $1.69B $1.71B
Pretax Income 10-point trend, +104.4% $9.83B $8.52B $7.71B $8.58B $9.83B $5.43B $5.24B $5.33B $4.38B $4.81B
Income Tax 10-point trend, +48.8% $2.05B $1.87B $1.61B $1.75B $2.11B $1.04B $1.10B $946M $1.64B $1.38B
Net Income 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
EPS (Basic) 10-point trend, +281.1% $28.70 $22.27 $19.25 $19.43 $21.52 $11.10 $10.27 $10.90 $6.12 $7.53
EPS (Diluted) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
Shares (Basic) 10-point trend, -38.4% 236,413,000 258,603,000 272,404,000 290,348,000 323,315,000 338,274,000 341,210,000 347,297,000 362,305,000 383,591,000
Shares (Diluted) 10-point trend, -39.5% 239,495,000 261,806,000 276,412,000 294,666,000 328,752,000 343,605,000 348,226,000 355,303,000 372,221,000 395,851,000
EBITDA 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
Balance Sheet 22
Annual Balance Sheet data for HCA
Metric Trend 2025202420232022202120202019201820172016
Cash & Equivalents 10-point trend, +61.0% $1.04B $1.93B $935M $908M $1.45B $1.79B $621M $502M $732M $646M
Short-term Investments 5-point trend, +136.7% · · · · · $116M $147M $47M $54M $49M
Receivables 10-point trend, +86.5% $10.87B $10.75B $9.96B $8.89B $8.10B $7.05B $7.38B $6.79B $6.50B $5.83B
Inventory 10-point trend, +9.9% $1.65B $1.74B $2.02B $2.07B $1.99B $2.02B $1.85B $1.73B $1.57B $1.50B
Other Current Assets 10-point trend, +100.2% $2.22B $1.99B $2.01B $1.78B $2.01B $1.46B $1.35B $1.19B $1.17B $1.11B
Current Assets 10-point trend, +73.7% $15.78B $16.41B $14.93B $13.64B $13.54B $12.33B $11.20B $10.21B $9.98B $9.09B
PP&E (Net) 10-point trend, +90.4% $31.14B $29.41B $27.71B $25.57B $24.06B $23.20B $22.71B $19.76B $17.89B $16.35B
PP&E (Gross) 10-point trend, +78.9% $66.28B $62.51B $58.55B $54.76B $51.35B $49.32B $47.23B $42.97B $40.08B $37.05B
Accum. Depreciation 10-point trend, +69.7% $35.13B $33.10B $30.83B $29.18B $27.29B $26.12B $24.52B $23.21B $22.19B $20.70B
Other Non-current Assets 10-point trend, -76.3% $255M $230M $184M $298M $598M $546M $480M $690M $710M $1.07B
Total Assets 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Accounts Payable 10-point trend, +101.0% $4.66B $4.28B $4.23B $4.24B $4.11B $3.54B $2.90B $2.58B $2.61B $2.32B
Current Liabilities 10-point trend, +180.3% $16.35B $15.18B $12.65B $9.90B $9.58B $8.70B $7.76B $7.57B $6.16B $5.83B
Capital Leases 7-point trend, +23.6% $1.85B $1.86B $1.90B $1.75B $1.75B $1.67B $1.50B · · ·
Total Liabilities 4-point trend, +15.8% · · · · · · $45.62B $42.12B $41.59B $39.39B
Long-term Debt 10-point trend, +41.1% $44.28B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Total Debt 10-point trend, +32.6% $41.60B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Retained Earnings 10-point trend, +17.9% $-5.72B $-2.12B $-1.35B $-2.28B $-532M $777M $-2.35B $-4.57B $-6.53B $-6.97B
AOCI 10-point trend, +9.8% $-305M $-387M $-425M $-490M $-404M $-502M $-460M $-381M $-278M $-338M
Stockholders' Equity 10-point trend, +17.5% $-6.03B $-2.50B $-1.77B $-2.77B $-933M $572M $-2.81B $-4.95B $-6.81B $-7.30B
Liabilities + Equity 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Shares Outstanding 10-point trend, -39.4% 224,605,100 249,981,400 265,537,300 277,378,300 305,476,800 339,425,600 338,445,600 342,895,200 350,091,600 370,535,900
Cash Flow 17
Annual Cash Flow data for HCA
Metric Trend 2025202420232022202120202019201820172016
D&A 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
Stock-based Comp 10-point trend, +59.8% $401M $360M $262M $341M $440M $362M $347M $268M $270M $251M
Amort. of Intangibles 6-point trend, -53.8% $12M $16M $20M $44M $25M $26M · · · ·
Other Non-cash 10-point trend, +172.2% $1.93B $1.08B $850M $-431M $-1.29B $2.40B $1.07B $461M $-3.53B $-2.67B
Operating Cash Flow 10-point trend, +123.5% $12.64B $10.51B $9.43B $8.52B $8.96B $9.23B $7.60B $6.76B $5.43B $5.65B
CapEx 10-point trend, +79.1% $4.94B $4.88B $4.74B $4.39B $3.58B $2.83B $4.16B $3.57B $3.02B $2.76B
Investing Cash Flow 10-point trend, -54.0% $-4.99B $-4.93B $-5.32B $-3.39B $-2.64B $-3.39B $-5.72B $-3.90B $-4.28B $-3.24B
Debt Issued 10-point trend, +56.9% $8.47B $7.50B $3.22B $6.00B $4.34B $2.70B $6.45B $2.00B $1.50B $5.40B
Net Debt Issued 10-point trend, +17.3% $1.08B $5.08B $2.31B $3.17B $475M $-737M $1.13B $296M $749M $925M
Stock Repurchased 10-point trend, +265.9% $10.07B $6.04B $3.81B $7.00B $8.21B $441M $1.03B $1.53B $2.05B $2.75B
Net Stock Activity 10-point trend, -265.9% $-10.07B $-6.04B $-3.81B $-7.00B $-8.21B $-441M $-1.03B $-1.53B $-2.05B $-2.75B
Dividends Paid 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·
Financing Cash Flow 10-point trend, -240.9% $-8.55B $-4.58B $-4.09B $-5.66B $-6.66B $-4.68B $-1.77B $-3.08B $-1.06B $-2.51B
Net Change in Cash 10-point trend, -840.0% $-893M $998M $27M $-543M $-342M $1.17B $119M $-230M $86M $-95M
Taxes Paid 10-point trend, +38.6% $1.74B $1.84B $1.39B $1.18B $2.18B $1.00B $849M $872M $1.21B $1.25B
Free Cash Flow 10-point trend, +165.9% $7.69B $5.64B $4.69B $4.13B $5.38B $6.40B $3.44B $3.19B $2.41B $2.89B
Levered FCF 10-point trend, +253.0% $5.91B $4.03B $3.16B $2.74B $4.15B $5.12B $2.00B $1.74B $1.35B $1.68B
Profitability 5
Annual Profitability data for HCA
Metric Trend 2025202420232022202120202019201820172016
Net Margin 8-point trend, +10.6% 9.0% 8.2% 8.1% 9.4% 11.8% 7.3% 6.8% 8.1% · ·
Pretax Margin 8-point trend, +13.8% 13.0% 12.1% 11.9% 14.2% 16.7% 10.5% 10.2% 11.4% · ·
EBITDA Margin 8-point trend, -4.5% 4.7% 4.7% 4.7% 4.9% 4.9% 5.3% 5.1% 4.9% · ·
ROA 10-point trend, +29.8% 11.3% 10.0% 9.7% 10.9% 14.2% 8.1% 8.3% 10.0% 6.3% 8.7%
ROE 10-point trend, -310.3% -159.1% -269.6% -230.9% -305.0% -3853.7% -335.8% -90.4% -64.4% -31.4% -38.8%
Liquidity & Solvency 4
Annual Liquidity & Solvency data for HCA
Metric Trend 2025202420232022202120202019201820172016
Current Ratio 10-point trend, -38.0% 1.0 1.1 1.2 1.4 1.4 1.4 1.4 1.3 1.6 1.6
Quick Ratio 10-point trend, -34.8% 0.7 0.8 0.9 1.0 1.0 1.0 1.1 1.0 1.2 1.1
Debt / Equity 10-point trend, -60.6% -6.9 -17.2 -22.3 -13.8 -37.1 54.2 -12.0 -6.6 -4.9 -4.3
LT Debt / Equity 10-point trend, -61.8% -6.9 -15.3 -21.0 -13.6 -36.8 53.8 -12.0 -6.5 -4.8 -4.3
Efficiency 2
Annual Efficiency data for HCA
Metric Trend 2025202420232022202120202019201820172016
Asset Turnover 8-point trend, +2.1% 1.3 1.2 1.2 1.2 1.2 1.1 1.2 1.2 · ·
Receivables Turnover 8-point trend, -0.4% 7.0 6.8 6.9 7.1 7.8 7.1 7.2 7.0 · ·
Per Share 6
Annual Per Share data for HCA
Metric Trend 2025202420232022202120202019201820172016
Book Value / Share 10-point trend, -36.2% $-26.83 $-10.00 $-6.68 $-9.98 $-3.05 $1.69 $-8.30 $-14.44 $-19.44 $-19.71
Revenue / Share 8-point trend, +140.3% $315.66 $269.68 $235.04 $204.41 $178.71 $149.98 $147.42 $131.37 · ·
Cash Flow / Share 10-point trend, +269.5% $52.76 $40.16 $34.12 $28.92 $27.25 $26.87 $21.83 $19.03 $14.58 $14.28
Cash / Share 10-point trend, +165.6% $4.63 $7.73 $3.52 $3.27 $4.75 $5.28 $1.83 $1.46 $2.09 $1.74
Dividend / Share 8-point trend, +105.7% $3 $3 $2 $2 $2 $0 $2 $1 · ·
EPS (TTM) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
Growth Rates 10
Annual Growth Rates data for HCA
Metric Trend 2025202420232022202120202019201820172016
Revenue YoY 5-point trend, -49.5% 7.1% 8.7% 7.9% 2.5% 14.0% · · · · ·
Revenue CAGR 3Y 3-point trend, -2.0% 7.9% 6.3% 8.0% · · · · · · ·
Revenue CAGR 5Y 8.0% · · · · · · · · ·
EPS YoY 5-point trend, -69.3% 28.8% 16.0% -0.94% -9.5% 93.6% · · · · ·
EPS CAGR 3Y 3-point trend, -30.9% 13.9% 1.3% 20.2% · · · · · · ·
EPS CAGR 5Y 21.0% · · · · · · · · ·
Net Income YoY 5-point trend, -79.2% 17.8% 9.9% -7.1% -18.9% 85.3% · · · · ·
Net Income CAGR 3Y 3-point trend, -46.2% 6.3% -6.1% 11.8% · · · · · · ·
Net Income CAGR 5Y 12.6% · · · · · · · · ·
Dividend CAGR 5Y 34.7% · · · · · · · · ·
Valuation (TTM) 17
Annual Valuation (TTM) data for HCA
Metric Trend 2025202420232022202120202019201820172016
Revenue TTM 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
Net Income TTM 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
Market Cap 10-point trend, +282.3% $104.86B $75.03B $71.88B $66.56B $78.48B $55.82B $50.03B $42.67B $30.75B $27.43B
Enterprise Value 10-point trend, +150.3% $145.42B $116.13B $110.53B $103.74B $111.61B $84.92B $82.98B $74.95B $63.02B $58.11B
P/E 10-point trend, +62.5% 16.5 13.6 14.3 12.5 12.1 15.0 14.7 11.7 14.8 10.1
P/S 10-point trend, +109.8% 1.4 1.1 1.1 1.1 1.3 1.1 1.0 0.9 0.7 0.7
P/B 10-point trend, -363.2% -17.4 -30.0 -40.5 -24.1 -84.1 97.6 -17.8 -8.6 -4.5 -3.8
P / Tangible Book · · · · · 97.6 · · · ·
P / Cash Flow 10-point trend, +71.0% 8.3 7.1 7.6 7.8 8.8 6.0 6.6 6.3 5.7 4.9
P / FCF 10-point trend, +43.8% 13.6 13.3 15.3 16.1 14.6 8.7 14.5 13.4 12.8 9.5
EV / EBITDA 10-point trend, +39.7% 41.3 35.1 35.9 34.9 39.1 31.2 32.0 32.9 29.6 29.6
EV / FCF 10-point trend, -5.9% 18.9 20.6 23.6 25.1 20.7 13.3 24.1 23.5 26.1 20.1
EV / Revenue 10-point trend, +37.4% 1.9 1.6 1.7 1.7 1.9 1.6 1.6 1.6 1.4 1.4
Dividend Yield 9-point trend, +0.01 0.65% 0.92% 0.92% 0.98% 0.80% 0.27% 1.1% 1.1% 0.00% ·
Earnings Yield 10-point trend, -38.4% 6.1% 7.3% 7.0% 8.0% 8.2% 6.7% 6.8% 8.6% 6.8% 9.9%
Payout Ratio 8-point trend, -22.2% 10.0% 12.0% 12.6% 11.6% 9.0% 4.1% 15.7% 12.9% · ·
Annual Payout 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $75.60B$70.60B$64.97B$60.23B$58.75B
Net Income $6.78B$5.76B$5.24B$5.64B$6.96B
Diluted EPS $28.33$22.00$18.97$19.15$21.16
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity -6.9-17.2-22.3-13.8-37.1
Current Ratio 1.01.11.21.41.4
Quick Ratio 0.70.80.91.01.0
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $7.69B$5.64B$4.69B$4.13B$5.38B

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 1,486 filers · $39.4B total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
128 (-51 vs prior Q) 174 (+70 vs prior Q) 450 (-30 vs prior Q) 555 (-4 vs prior Q) +16.3M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $6,118,113,464 13,104,814 15.52% Shares
VANGUARD CAPITAL MANAGEMENT LLC $3,954,150,533 10,141,708 10.03% Shares
Sanders Capital, LLC $3,442,060,818 8,828,287 8.73% Shares
STATE STREET CORP $2,912,102,056 7,469,035 7.39% Shares
WELLINGTON MANAGEMENT GROUP LLP $1,750,298,867 4,489,212 4.44% Shares
GEODE CAPITAL MANAGEMENT, LLC $1,225,259,672 3,159,159 3.11% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $1,057,704,509 2,712,828 2.68% Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $861,456,107 2,209,485 2.19% Shares
NORGES BANK $836,457,140 2,145,367 2.12% Shares
Capital World Investors $770,864,224 1,977,121 1.96% Shares
Capital International Investors $747,403,041 1,916,947 1.90% Shares
Crake Asset Management LLP $449,072,183 1,151,792 1.14% Shares
Metropolis Capital Ltd $430,915,307 910,564 1.09% Shares
Darsana Capital Partners LP $428,879,000 1,100,000 1.09% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $414,533,777 1,063,207 1.05% Shares
Life Cycle Investment Partners Ltd $355,737,196 912,404 0.90% Shares
VANGUARD FIDUCIARY TRUST CO $339,685,814 871,235 0.86% Shares
FMR LLC $325,199,295 834,080 0.83% Shares
BARCLAYS PLC $299,888,573 769,162 0.76% Shares
LYRICAL ASSET MANAGEMENT LP $255,015,742 654,071 0.65% Shares
BlackRock, Inc. $240,062,291 615,718 0.61% Shares
ROYAL LONDON ASSET MANAGEMENT LTD $235,649,908 604,401 0.60% Shares
National Pension Service $230,650,346 591,578 0.59% Shares
NORDEA INVESTMENT MANAGEMENT AB $230,189,125 594,466 0.58% Shares
GOLDMAN SACHS GROUP INC $209,775,669 538,038 0.53% Shares
Gobi Capital LLC $195,742,325 502,045 0.50% Shares
Cryder Capital Partners LLP $194,561,738 499,017 0.49% Shares
Swiss National Bank $172,097,446 441,400 0.44% Shares
AustralianSuper Pty Ltd $159,635,782 409,438 0.41% Shares
Consulta Ltd $155,956,000 400,000 0.40% Shares
LEE DANNER & BASS INC $152,150,679 390,240 0.39% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $151,472,265 388,500 0.38% Call option
Mitsubishi UFJ Asset Management Co., Ltd. $147,943,761 379,450 0.38% Shares
DIMENSIONAL FUND ADVISORS LP $139,697,405 358,300 0.35% Shares
Vanguard Global Advisers, LLC $136,962,509 351,285 0.35% Shares
VIRGINIA RETIREMENT SYSTEMS ET Al $134,838,505 288,820 0.34% Shares
ALLIANCEBERNSTEIN L.P. $134,459,788 284,126 0.34% Shares
Sumitomo Mitsui Trust Group, Inc. $132,794,974 340,596 0.34% Shares
TD Asset Management Inc $131,847,152 338,165 0.33% Shares
Legal & General Group Plc $127,805,162 327,798 0.32% Shares
California Public Employees Retirement System $124,133,958 318,382 0.31% Shares
LAZARD ASSET MANAGEMENT LLC $120,619,879 309,369 0.31% Shares
JANE STREET GROUP, LLC $119,540,274 306,600 0.30% Call option
VANGUARD ASSET MANAGEMENT, Ltd $116,069,863 297,699 0.29% Shares
CAPTRUST FINANCIAL ADVISORS $114,741,071 294,291 0.29% Shares
ANTIPODES PARTNERS Ltd $113,045,096 289,941 0.29% Shares
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $109,718,328 231,845 0.28% Shares
CITADEL ADVISORS LLC $105,660,190 271,000 0.27% Call option
RHUMBLINE ADVISERS $97,580,413 250,277 0.25% Shares
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $97,026,076 248,855 0.25% Shares
MACKENZIE FINANCIAL CORP $93,597,383 240,061 0.24% Shares
BloombergSen Inc. $93,160,317 238,940 0.24% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $92,247,974 236,600 0.23% Put option
Brandywine Global Investment Management, LLC $89,380,814 191,451 0.23% Shares
BANK OF AMERICA CORP /DE/ $89,069,981 228,449 0.23% Shares
NEUBERGER BERMAN GROUP LLC $85,926,216 220,386 0.22% Shares
MILFORD FUNDS LTD $82,165,029 210,739 0.21% Shares
Bridgewater Associates, LP $79,227,208 203,204 0.20% Shares
Prana Capital Management, LP $75,552,494 193,779 0.19% Shares
DANSKE BANK A/S $73,238,497 187,844 0.19% Shares
FRANKLIN RESOURCES INC $70,965,828 182,015 0.18% Shares
VOLORIDGE INVESTMENT MANAGEMENT, LLC $70,445,715 180,681 0.18% Shares
Quantinno Capital Management LP $70,407,055 180,581 0.18% Shares
ARGENT CAPITAL MANAGEMENT LLC $69,149,681 177,357 0.18% Shares
Retirement Systems of Alabama $68,081,812 174,618 0.17% Shares
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $66,167,842 169,709 0.17% Shares
BNP PARIBAS FINANCIAL MARKETS $64,793,090 166,183 0.16% Shares
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $64,665,206 165,855 0.16% Shares
HSBC HOLDINGS PLC $64,431,534 165,332 0.16% Shares
AVIVA PLC $64,264,789 164,828 0.16% Shares
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $64,194,533 135,649 0.16% Shares
SEB Asset Management AB $63,257,255 162,244 0.16% Shares
TODD ASSET MANAGEMENT LLC $62,567,208 160,474 0.16% Shares
Swedbank AB $62,528,998 160,376 0.16% Shares
W1M Investment Management Ltd $61,247,490 143,647 0.16% Shares
HARRIS ASSOCIATES L P $60,080,879 154,097 0.15% Shares
Ensign Peak Advisors, Inc $58,372,381 149,715 0.15% Shares
NEW YORK STATE COMMON RETIREMENT FUND $57,747,778 148,113 0.15% Shares
CITADEL ADVISORS LLC $57,235,852 146,800 0.15% Put option
Universal- Beteiligungs- und Servicegesellschaft mbH $57,160,993 146,800 0.15% Shares
LOS ANGELES CAPITAL MANAGEMENT LLC $56,512,217 144,944 0.14% Shares
Pictet Asset Management Holding SA $52,147,803 133,739 0.13% Shares
VICTORY CAPITAL MANAGEMENT INC $50,752,761 130,172 0.13% Shares
Pentwater Capital Management LP $50,685,700 130,000 0.13% Shares
D. E. Shaw & Co., Inc. $50,554,307 129,663 0.13% Shares
APG Asset Management N.V. $50,368,550 147,699 0.13% Shares
AMF Tjanstepension AB $50,355,853 129,154 0.13% Shares
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $50,349,225 129,137 0.13% Shares
EQUITABLE TRUST CO $49,147,974 126,056 0.12% Shares
ENVESTNET ASSET MANAGEMENT INC $48,919,124 125,469 0.12% Shares
CANADA PENSION PLAN INVESTMENT BOARD $48,197,812 123,619 0.12% Shares
AMERICAN CENTURY COMPANIES INC $47,460,140 121,727 0.12% Shares
OpenArc Corporate Advisory, LLC $47,210,610 121,087 0.12% Shares
L1 Capital International Pty Ltd $46,121,648 118,294 0.12% Shares
FIRST TRUST ADVISORS LP $44,251,579 113,498 0.11% Shares
PFA Pension, Forsikringsaktieselskab $44,046,098 112,971 0.11% Shares
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund $43,830,264 112,417 0.11% Shares
EP Wealth Advisors, LLC $43,287,826 111,026 0.11% Shares
WOLVERINE TRADING, LLC $42,597,104 101,200 0.11% Call option
MERCER GLOBAL ADVISORS INC /ADV $42,302,070 108,497 0.11% Shares

Company insiders 91 insiders · 54 officers · 31 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Samuel N Hazen CEO Feb. 10, 2026 F 64,842 0 7 $-21,483,290
O'Boyle Michael P President & CEO - Parallon Feb. 26, 2013 A 21,429 0 0 $0
Mike A Marks EVP and CFO May 7, 2026 G 46,576 0 0 $0
Bill B Rutherford CFO and EVP Feb. 16, 2024 F 22,251 0 0 $0
Russell K Harms CFO - Central Group Nov. 17, 2006 D 0 0 0 $0
Robert Samuel Hankins JR CFO-Outpatient Services Group Nov. 17, 2006 D 0 0 0 $0
Richard J Shallcross CFO - Western Group Nov. 17, 2006 D 0 0 0 $0
Jeffrey T Crudele CFO-Eastern Division July 1, 2005 F 13,865 0 0 $0
Erol R Akdamar Group President Nov. 12, 2024 M 6,843 0 0 $0
Timothy M Mcmanus Group President July 31, 2024 M 27,008 0 0 $0
Richard A Hammett Group President Feb. 16, 2024 F 17,936 0 0 $0
Charles J Hall Group President Nov. 11, 2022 M 202,443 0 0 $0
Bruce A Moore JR Group President - Service Line Nov. 11, 2022 S 30,807 0 0 $0
Paul W Rutledge Group President Dec. 31, 2012 A 335,657 0 0 $0
Beverly B Wallace President - Parallon Nov. 2, 2011 M 144,714 0 0 $0
Charles Robert Evans President - Eastern Group July 26, 2006 A 62,173 0 0 $0
Marilyn B Tavenner President-Outpatient Svcs Grp Oct. 27, 2005 A 26,154 0 0 $0
Greg Roth President-Ambulatory Surgery Oct. 31, 2004 D 9,029 0 0 $0
Jay Grinney President-Eastern Group May 7, 2004 D 24,177 0 0 $0
Jon M Foster EVP and COO Feb. 10, 2026 F 23,062 0 0 $0
Michael R Mcalevey EVP & Chief Legal & Admin Off. Feb. 13, 2026 M 8,853 0 2 $-2,747,520
Jennifer Berres SVP & Chief Human Res. Officer Feb. 11, 2026 S 11,993 0 2 $-4,126,932
Christopher F. Wyatt SVP & Controller Feb. 11, 2026 S 44,379 0 1 $-2,020,000
Erica Rossitto SVP & Chief Nurse Executive Feb. 10, 2026 F 10,407 0 0 $0
Michael S. Cuffe EVP and Chief Clinical Officer Feb. 10, 2026 F 32,080 0 1 $-747,135
Sammie S Mosier SVP & Chief Nurse Executive Feb. 13, 2025 F 11,113 0 0 $0
Kathleen M Whalen SVP & Chief Ethics Officer Nov. 14, 2024 S 9,454 0 0 $0
Phillip G Billington SVP-Internal Audit Services Nov. 12, 2024 M 52,702 0 0 $0
Joseph A Sowell III SVP; Chief Development Officer Aug. 5, 2024 G 18,526 0 0 $0
Deborah M Reiner SVP - Mktg. & Communications July 29, 2024 S 3,510 0 0 $0
Kathryn A. Torres SVP-Payer Contracting & Align. July 25, 2024 S 17,755 0 0 $0
Jeffrey E. Cohen SVP-Government Relations May 9, 2024 S 5,185 0 0 $0
Chad J Wasserman SVP and CIO March 18, 2024 M 1,576 0 0 $0
Martin P. Paslick SVP and CIO April 12, 2023 M 24,643 0 0 $0
Jane D. Englebright SVP and Chief Nursing Officer Nov. 9, 2021 S 0 0 0 $0
Robert A Waterman SVP & General Counsel May 5, 2021 S 50,062 0 0 $0
William J Morrow SVP - Finance and Treasurer Feb. 18, 2021 F 5,578 0 0 $0
Sandra L. Morgan SVP-Provider Relations Feb. 18, 2021 F 10,122 0 0 $0
Victor L Campbell SVP-Government Affairs May 1, 2019 A 194,145 0 0 $0
John M Steele SVP & Chief Human Res. Officer Feb. 25, 2019 M 84,157 0 0 $0
Milton R Johnson Chairman Feb. 25, 2019 M 881,823 0 0 $0
Ravi S. Chari SVP-Clinical Excellence Feb. 25, 2018 M 7,003 0 0 $0
Alan R Yuspeh SVP & Chief Ethics Officer Feb. 25, 2018 M 35,546 0 0 $0
Joseph N Steakley SVP-Internal Audit Services Feb. 25, 2018 M 65,199 0 0 $0
Jana Joustra Davis SVP - Mktg. & Corp. Affairs May 23, 2017 M 26,378 0 0 $0
David Gwin Anderson SVP - Finance Nov. 7, 2016 M 110,167 0 0 $0
Donald W Stinnett SVP & Controller Feb. 25, 2016 A 51,965 0 0 $0
Noel B Williams SVP and CIO May 16, 2012 M 299,030 0 0 $0
Jack O Bovender JR Chairman Oct. 6, 2009 A 188,340 0 0 $0
Carl V George SVP - Development Feb. 27, 2009 M 13,092 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 4 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan Feb. 10, 2026 31.60% Initial filing SEC
Nov. 22, 2006 Initial filing SEC
Merrill Lynch Bank USA Sept. 11, 2006 Initial filing SEC
Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC Aug. 4, 2006 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 207 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IHF · iShares Trust 4.67% 141,320 SH Aug. 8, 2026 Daily
BUL · Pacer Funds Trust 3.91% 11,437 NS April 30, 2026 N-PORT
YALL · Tidal Trust I 3.61% 9,261 NS May 31, 2026 N-PORT
BWTG · ETF Opportunities Trust 3.02% 1,646 NS May 31, 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 2.32% 99,335 SH Aug. 8, 2026 Daily
ABIG · EA Series Trust 2.00% 2,938 NS May 29, 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 1.99% 39,985 NS April 30, 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1.67% 31,685 SH Aug. 8, 2026 Daily
COWZ · Pacer Funds Trust 1.64% 688,264 NS April 30, 2026 N-PORT
QQWZ · Pacer Funds Trust 1.64% 1,762 NS April 30, 2026 N-PORT
FEGE · RBB Fund Trust 1.46% 74,706 NS May 31, 2026 N-PORT
PWV · Invesco Exchange-Traded Fund Trust 1.39% 60,385 SH Aug. 8, 2026 Daily
RPG · Invesco Exchange-Traded Fund Trust 1.30% 63,448 SH Aug. 8, 2026 Daily
TMFE · RBB Fund, Inc. 1.29% 2,892 NS May 31, 2026 N-PORT
AMID · EA Series Trust 1.23% 3,402 NS May 29, 2026 N-PORT
FCPI · FIDELITY COVINGTON TRUST 1.15% 7,180 NS April 30, 2026 N-PORT
FMAG · FIDELITY COVINGTON TRUST 1.12% 6,544 NS April 30, 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 1.12% 73,639 NS April 30, 2026 N-PORT
SRHQ · Elevation Series Trust 1.10% 4,883 NS April 30, 2026 N-PORT
IYH · iShares Trust 0.99% 89,420 SH Aug. 8, 2026 Daily
NEAR · iShares U.S. ETF Trust 0.99% 48,109,000 SH Aug. 8, 2026 Daily
CURE · Direxion Shares ETF Trust 0.98% 3,122 NS April 30, 2026 N-PORT
VHT · VANGUARD WORLD FUND 0.90% 470,451 SH Aug. 8, 2026 Daily
NFRA · FlexShares Trust 0.88% 62,176 NS April 30, 2026 N-PORT
REVS · Columbia ETF Trust I 0.87% 5,693 NS April 30, 2026 N-PORT
RXL · ProShares Trust 0.86% 1,632 NS May 31, 2026 N-PORT
DIVB · iShares Trust 0.85% 36,806 SH Aug. 8, 2026 Daily
BSCT · Invesco Exchange-Traded Self-Indexe… 0.82% 24,078,000 Aug. 8, 2026 Daily
LSEQ · Harbor ETF Trust 0.81% 285 NS April 30, 2026 N-PORT
IXJ · iShares Trust 0.80% 81,465 SH Aug. 8, 2026 Daily
BSCS · Invesco Exchange-Traded Self-Indexe… 0.76% 26,493,000 Aug. 8, 2026 Daily
SPVM · Invesco Exchange-Traded Fund Trust 0.74% 2,335 SH Aug. 8, 2026 Daily
FTC · First Trust Exchange-Traded AlphaDE… 0.73% 21,329 NS April 30, 2026 N-PORT
RFFC · ALPS ETF Trust 0.68% 533 NS May 31, 2026 N-PORT
QUVU · Hartford Funds Exchange-Traded Trust 0.68% 2,698 NS April 30, 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0.67% 12,075 SH Aug. 8, 2026 Daily
VCEB · VANGUARD WORLD FUND 0.62% 8,146,000 PA Aug. 8, 2026 Daily
FDMO · FIDELITY COVINGTON TRUST 0.61% 11,771 NS April 30, 2026 N-PORT
RECS · Columbia ETF Trust I 0.58% 72,768 NS April 30, 2026 N-PORT
AFLG · First Trust Exchange-Traded Fund VI… 0.56% 9,664 NS May 31, 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0.55% 11,876 SH Aug. 8, 2026 Daily
VLLU · Harbor ETF Trust 0.54% 54 NS April 30, 2026 N-PORT
LSVD · ADVISORS' INNER CIRCLE FUND 0.53% 7,404 NS April 30, 2026 N-PORT
WLDR · Two Roads Shared Trust 0.51% 844 NS April 30, 2026 N-PORT
VALQ · AMERICAN CENTURY ETF TRUST 0.50% 4,620 NS May 31, 2026 N-PORT
AKAF · ETF Series Solutions 0.50% 39 NS May 31, 2026 N-PORT
BSCR · Invesco Exchange-Traded Self-Indexe… 0.50% 22,679,000 Aug. 8, 2026 Daily
ROUS · Lattice Strategies Trust 0.47% 6,388 NS April 30, 2026 N-PORT
VCLT · VANGUARD SCOTTSDALE FUNDS 0.46% 54,218,000 PA Aug. 8, 2026 Daily
CGGR · Capital Group Growth ETF 0.45% 290,273 NS May 31, 2026 N-PORT